Background: Acute interstitial nephritis (AIN) is an important cause of reversible acute kidney injury. At least 70% of AIN is caused by various drugs, mainly penicillines and non-steroidal anti-inflammatory drugs. Quinolones are only rarely known to cause AIN and so far cases have been mainly described with older fluoroquinolones. Case Presentation: Here we describe a case of biopsy proven interstitial nephritis after moxifloxacin treatment. The patient presented with fever, rigors and dialysis dependent acute kidney injury, just a few days after treatment of a respiratory tract infection with moxifloxacin. The renal biopsy revealed dense infiltrates mainly composed of eosinophils and severe interstitial edema. A course of oral prednisolone (1 mg/kg/day) was commenced and rapidly tapered to zero within three weeks. The renal function improved, and the patient was discharged with a creatinine of 107 mol/l. Conclusion: This case illustrates that pharmacovigilance is important to early detect rare side effects, such as AIN, even in drugs with a favourable risk/benefit ratio such as moxifloxacin. © 2010 Chatzikyrkou et al; licensee BioMed Central Ltd.
CITATION STYLE
Chatzikyrkou, C., Hamwi, I., Clajus, C., Becker, J., Hafer, C., & Kielstein, J. T. (2010). Biopsy proven acute interstitial nephritis after treatment with moxifloxacin. BMC Nephrology, 11(1). https://doi.org/10.1186/1471-2369-11-19
Mendeley helps you to discover research relevant for your work.